封面
市場調查報告書
商品編碼
1550720

全球生物晶片市場:依產品類型、最終用戶、地區

Biochips Market, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球生物晶片市場規模預計將從2024年的115億美元增加至2031年的321.5億美元,2024年至2031年的複合年成長率為15.8%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 115億美元
實際資料 2019-2023 預測期 2024-2031
預測 2024-2031 年複合年成長率: 15.80% 2031年價值預測 321.5億美元
圖:2024 年按地區分類的生物晶片市場佔有率(%)
生物晶片市場-IMG1

全球生物晶片市場由用於檢測和識別生物分子的技術組成,從病原體和基因到蛋白質和 DNA 序列。生物晶片用於藥物發現、疾病診斷、食品安全等。市場開拓是由政府和私人組織加強研發力度以及提供資金來開發創新生物感測器技術所推動的。分子生物學領域的進步和精準醫療的興起正在加速生物晶片在整個產業的採用。生物晶片設計和製造流程的改進可能在不久的將來提供利潤豐厚的成長機會。

市場動態:

全球生物晶片市場的成長是由癌症等疾病盛行率上升以及對早期診斷的關注所推動的。對生物技術和生命科學研究的投資不斷增加也推動了在微觀層面檢測生物分子之間相互作用的生物晶片的需求。然而,生物晶片的開發成本高昂,嚴格的監管標準可能會延遲產品核准。缺乏熟練的專業人員正在阻礙生物晶片的廣泛使用。開發中國家開拓的商機提供了豐厚的前景。微陣列和微流體技術的出現提高了生物晶片的檢測能力,並將其應用領域從醫療保健擴展到環境監測和食品安全檢測。

本研究的主要特點

這份報告對全球生物晶片市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031年)的市場規模(十億美元)和年複合成長率(CAGR%)。 。

它揭示了各個細分市場的潛在商機,並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數,介紹了全球生物晶片市場的主要企業。

主要公司包括 Illumina、Thermo Fisher Scientific Inc.、Agilent Technologies、Bio-Rad Laboratories Inc.、PerkinElmer Inc.、Fluidigm Corporation 和 GE Healthcare。

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球生物晶片市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球生物晶片市場的各種策略矩陣,將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球生物晶片市場 - 新型冠狀病毒(COVID-19)大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章全球生物晶片市場:依產品類型(2019-2031)

  • DNA晶片
  • 癌症診斷和治療
  • 基因表現
  • SNP基因型鑒定
  • 基因組學
  • 藥物發現
  • 農業生物技術
  • 其他
  • 蛋白質晶片
  • 蛋白質體學
  • 表達譜
  • 診斷
  • HTS
  • 其他
  • 實驗室晶片
  • 體外診斷和POC
  • 其他
  • 組織陣列
  • 單元陣列

第6章 全球生物晶片市場:依最終用戶分類(2019-2031)

  • 生物技術和製藥公司
  • 學術研究所
  • 醫院和診斷中心
  • 其他

第7章全球生物晶片市場:按地區(2019-2031)

  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東

第8章 競爭格局

  • 公司簡介
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Fluidigm Corporation
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • F. Hoffmann-La Roche AG
    • QIAGEN
    • Randox Laboratories Ltd
    • LI-COR, Inc.
    • Merck KGaA
    • Becton, Dickinson and Company
    • Arrayit Corporation
    • Nanostring Technologies, Inc.
    • GnuBio, Inc.

第9章 分析師建議

  • Wheel of Fortune
  • 分析師觀點
  • Coherent Opportunity Map(COM)

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1146

Global biochips market is estimated to be valued at USD 11.50 Bn in 2024 and is expected to reach USD 32.15 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 11.50 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 15.80% 2031 Value Projection: US$ 32.15 Bn
Figure. Biochips Market Share (%), By Region 2024
Biochips Market - IMG1

Global biochips market consists of technology used for detecting and identifying biological molecules from pathogens and genes to proteins and DNA sequences. Biochips are used in drug discovery, disease diagnosis, and food safety, among others. Increasing R&D efforts and funding from governments and private organizations for developing innovative biosensor technologies can drive the market growth. Advancements in fields of molecular biology and rise of precision medicine have accelerated the adoption of biochips across industries. Enhancements in biochip design and manufacturing processes can offer lucrative growth opportunities in the near future.

Market Dynamics:

Global biochips market growth is driven by rising prevalence of diseases like cancer and focus on early diagnosis. Growing investments in biotechnology and life science research also boosts demand for biochips to detect biomolecular interactions at microscopic levels. However, high costs associated with biochip development and strict regulatory norms can delay product approvals. Lack of skilled professionals can hamper its wider adoption. Untapped opportunities in developing nations present lucrative prospects. Emergence of microarray and microfluidic technology have improved detection capacities of biochips, thus, expanding application areas from healthcare to environmental monitoring and food safety testing.

Key features of the study:

This report provides in-depth analysis of the global biochips market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biochips market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., PerkinElmer Inc., Fluidigm Corporation, and GE Healthcare

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biochips market

Detailed Segmentation-

  • By Product Type
    • DNA Chips
    • Cancer Diagnosis and Treatment
    • Gene Expression
    • SNP Genotyping
    • Genomics
    • Drug Discovery
    • Agricultural Biotechnology
    • Others
    • Protein Chips
    • Proteomics
    • Expression Profiling
    • Diagnostics
    • HTS
    • Others
    • Lab-on-chip
    • IVD & POC
    • Others
    • Tissue Arrays
    • Cell Arrays
  • By End User
    • Biotechnology and Pharmaceutical Companies
    • Academic & Research Institutes
    • Hospitals and Diagnostic Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Fluidigm Corporation
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • Hoffmann-La Roche AG
    • QIAGEN
    • Randox Laboratories Ltd
    • LI-COR, Inc.
    • Merck KGaA
    • Becton, Dickinson and Company
    • Arrayit Corporation
    • Nanostring Technologies, Inc.
    • GnuBio, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Biochips Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Biochips Market, By Product Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • DNA Chips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cancer Diagnosis and Treatment
  • Gene Expression
  • SNP Genotyping
  • Genomics
  • Drug Discovery
  • Agricultural Biotechnology
  • Others
  • Protein Chips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Proteomics
  • Expression Profiling
  • Diagnostics
  • HTS
  • Others
  • Lab-on-chip
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • IVD & POC
  • Others
  • Tissue Arrays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cell Arrays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Biochips Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Biotechnology and Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Academic & Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hospitals and Diagnostic Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Biochips Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fluidigm Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Illumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • F. Hoffmann-La Roche AG
    • QIAGEN
    • Randox Laboratories Ltd
    • LI-COR, Inc.
    • Merck KGaA
    • Becton, Dickinson and Company
    • Arrayit Corporation
    • Nanostring Technologies, Inc.
    • GnuBio, Inc.

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact